Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Colistin-resistant Isolates From Patients Admitted in Intensive Care Units and Oncohaematology Wards in the Region Nouvelle Aquitaine: Diagnostic Accuracy of the Detection Methods, Estimation of the Prevalence and Description of the Resistance Mechanisms.

NCT03971877 is registered in ClinicalTrials.gov with University Hospital, Bordeaux as lead sponsor.

NCT NCT03971877
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03971877 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Colistin-resistant Isolates From Patients Admitted in Intensive Care Units and Oncohaematology Wards in the Region Nouvelle Aquitaine: Diagnostic Accuracy of the Detection Methods, Estimation of the Prevalence and Description of the Resistance Mechanisms.
Lead sponsor
University Hospital, Bordeaux
Phase
Observational
Overall status
Completed
Start date
December 16, 2019
Completion date
February 16, 2021
Enrollment
1,934 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

colistin resistance in bacteria